Mutation frequencies of <em>EGFR</em> and <em>KRAS</em> were 30 and 10 percent, respectively, and 23 and 13 percent, respectively, for Mexican and Colombian patients
Restricted mean survival time difference was 0.84 years at 10 years for women undergoing pulmonary resection<strong></strong>
People of color face worse outcomes, have lower likelihood of being diagnosed early, receiving surgery
Lung cancer screening at the state level does not correlate with lung cancer burden
Interim analysis shows risk for disease progression or death lower for first-line therapy with lorlatinib versus crizotinib
Guidelines reduce postoperative opioid prescribing but may result in inadequate pain control for some
Use of ACE-I/ARB versus nonuse linked to lower mortality for those hospitalized with flu, pneumonia